Exelon Rally: Strong Q4, $41B Capex, Rate Wins Now

Exelon (NASDAQ: EXC) moved decisively higher on Feb. 12 after the company released fourth-quarter and full-year 2025 results and set a clear financial roadmap for 2026 and beyond. Investors reacted to a combination of steady full-year earnings, forward guidance, large-scale capital commitments, and regulatory approvals that collectively improve earnings visibility for the utility holding company.

What drove the Feb. 12 price action?

On Feb. 12 Exelon shares rose sharply, closing at $47.55 on unusually high volume — roughly 24.2 million shares traded, several times its recent daily average. The move put the stock within striking distance of its 52-week high ($48.51), signaling investor enthusiasm for the company’s near-term trajectory.

Key market signals

• Strong trading volume, indicating conviction behind the move.
• Price approaching a 52-week high, which can attract momentum-driven flows.
• News flow that tied operational and regulatory developments directly to cashflow and earnings outlook.

Financials and guidance: steady now, growth ahead

Exelon reported Q4 GAAP net income of $0.58 per share and adjusted operating earnings of $0.59 per share — slightly below the prior-year quarter. For the full year 2025, GAAP net income was $2.73 and adjusted EPS was $2.77, both up from 2024. More important to investors was the forward-looking guidance: Exelon set a 2026 adjusted EPS range of $2.81–$2.91, implying continued year‑over‑year growth and a multi-year target of 5–7% annualized operating EPS growth through 2029.

Dividend and capital allocation

Management declared a quarterly dividend of $0.42 per share (payable March 13, 2026; shareholders of record March 2, 2026). At the same time Exelon unveiled a four-year capital program totaling $41.3 billion. That capex drive is intended to support grid resilience, generation investments and regulated utility growth — a core engine for expanding rate base and future earnings.

Regulatory wins that matter to EXC

Two recent regulatory outcomes were highlighted as contributors to more predictable near-term revenue:

• Illinois Commerce Commission approval for ComEd that increases revenue requirements by approximately $243 million effective Jan. 1, 2026.
• Maryland Public Service Commission approval allowing BGE to recover roughly $77 million in under-collected revenues effective Feb. 1, 2026, plus recognition of an additional $28 million in regulatory assets.

Those decisions reduce short-term regulatory uncertainty and improve cash recovery timelines — especially important for utilities whose returns depend on allowed rate base and timely cost recovery.

Why these items matter together

Think of Exelon’s profile as two engines: regulated utilities that deliver predictable cash flows through rate-base expansion, and generation operations that add operating-scale and flexibility. The capex plan feeds the first engine; the rate-case approvals ensure the company can recover investments and operating costs. Combined with forward EPS guidance, investors can now model earnings with greater confidence — which likely explains the pronounced buying interest.

Bottom line

Recent, verifiable developments — Feb. 12 earnings and guidance, a $41.3 billion capex plan, a maintained dividend, and concrete regulatory approvals for ComEd and BGE — created a clearer earnings trajectory for Exelon. Those event-driven factors produced a tangible market response and materially affect near-term cashflow and mid-term growth assumptions for EXC. The company’s positioning now favors investors focused on regulated-rate base growth and visible multi-year EPS expansion.

Disclosure: This article summarizes recent, event-driven information about Exelon; it is not investment advice.